LexDanaLexDanabeta
Inventor

ATSUFUMI KAWABATA

Inventor
JP

Overview

3→
Patents
2022
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes25%
PatentTitleYear
11,479,537T-type calcium channel inhibitor202211,420,944Voltage-dependent t-type calcium channel blocker202211,370,761Voltage-dependent T-type calcium channel inhibitor2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to UNIV KINKI (3)· patent assignee history
2022Patents assigned to NIPPON CHEMIPHAR CO (2)· patent assignee history
2022Patents assigned to FUSO PHARMACEUTICAL IND (1)· patent assignee history
2022Patents assigned to NATIONAL UNIV CORPORATION UNIV OF TOYAMA (1)· patent assignee history
2022Based in JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV KINKI32022
NIPPON CHEMIPHAR CO22022
FUSO PHARMACEUTICAL IND12022
NATIONAL UNIV CORPORATION UNIV OF TOYAMA12022
Locations
LocationPatentsSpan
JP32022